01570nam 2200445Ia 450 991069887000332120090511160404.0(CKB)5470000002397164(OCoLC)320778975(EXLCZ)99547000000239716420090511d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignanciesRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2006]ii, 46 pages digital, PDF fileTitle from PDF title page (viewed on May 11, 2009)."Draft guidance.""December 2006".Includes bibliographical references (page 46).Guidance for industry Fetal bloodHematopoiesisHematomaBlood banksLicensesUnited StatesFetal blood.Hematopoiesis.Hematoma.Blood banksLicensesCenter for Biologics Evaluation and Research (U.S.)GPOGPOGPOBOOK9910698870003321Guidance for industry3434577UNINA